{"id":"https://genegraph.clinicalgenome.org/r/a4944d45-48f4-485b-87b6-01d7ef2dfcbav1.0","type":"EvidenceStrengthAssertion","dc:description":"ZIC1 was first reported in relation to autosomal dominant craniosynostosis 6 in 2015 (Twigg et al., PMID: 26340333). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found differences in molecular mechanism, inheritance pattern, and phenotypic variability. Therefore, the following disease entities have been split into multiple disease entities craniosynostosis 6 (OMIM: 616602) and structural brain anomalies without craniosynostosis (no OMIM term). The split curation for autosomal recessive structural brain anomalies without craniosynostosis will be curated separately. Ten variants (missense, frameshift, nonsense) that have been reported in at least 17 probands in 8 publications (PMIDs: 26340333, 27884935, 30391508, 32975022, 33288889, 35591945, 36118902, 37086723) are included in this curation. The variants associated with this disease are all in the C-terminal region, the disruption of which enhances en-2 expression. The mechanism of pathogenicity is reported to be gain-of-function. This gene-disease relationship is also supported by experimental evidence (GTEx expression data, Xenopus oocyte functional evidence; PMID: 26340333). In summary, there is definitive evidence supporting the relationship between ZIC1 and autosomal dominant craniosynostosis 6. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Craniofacial Malformations GCEP on the meeting date 1/18/2024 (SOP Version 10). ","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/a4944d45-48f4-485b-87b6-01d7ef2dfcba","GCISnapshot":"https://genegraph.clinicalgenome.org/r/e70d90a2-6365-49ac-a21f-599ff5906d88","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/e70d90a2-6365-49ac-a21f-599ff5906d88_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10059","date":"2024-04-01T12:46:21.484Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/e70d90a2-6365-49ac-a21f-599ff5906d88_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10059","date":"2024-01-18T17:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e70d90a2-6365-49ac-a21f-599ff5906d88_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/25664c62-4c1a-44cd-968a-2f86fa4df0f6","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/25664c62-4c1a-44cd-968a-2f86fa4df0f6_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mutation disrupted a significant amount of zebrafish embryos and enhanced en-2 (engrailed 2) expression.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/25664c62-4c1a-44cd-968a-2f86fa4df0f6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26340333","allele":{"id":"https://genegraph.clinicalgenome.org/r/038849d0-e78c-42a3-81b1-00dfd567b3b1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003412.4(ZIC1):c.1198G>C (p.Gly400Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16042226"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9507fddd-d36f-4831-ba8d-a0fd59d97a77","type":"EvidenceLine","dc:description":"Since the mechanism of disease is gain-of-function, I'm adding 0.9 for the functional evidence instead of 0.4. Also, there is radiographic evidence showing bicoronal synostosis, a large wormian bone in the position of the anterior fontanelle, and ossification anomaly in the sagittal suture.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9507fddd-d36f-4831-ba8d-a0fd59d97a77_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mutation disrupted a significant amount of zebrafish embryos and enhanced en-2 (engrailed 2) expression.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/9507fddd-d36f-4831-ba8d-a0fd59d97a77_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26340333","allele":{"id":"https://genegraph.clinicalgenome.org/r/31dc3705-d855-4f6f-abba-23df9048cc86","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003412.4(ZIC1):c.1204G>T (p.Glu402Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16042225"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/41d0d43e-b04d-4e7a-a0a4-c23ac67c1cf5","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/41d0d43e-b04d-4e7a-a0a4-c23ac67c1cf5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37086723","allele":{"id":"https://genegraph.clinicalgenome.org/r/0f16675f-de98-4e67-af76-6caf22cbbc62","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003412.4(ZIC1):c.1042G>A (p.Asp348Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA354898090"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/3265c447-f449-4ac5-b38b-d262a5fe99f0","type":"EvidenceLine","dc:description":"Variant was suspected, but not confirmed, to be de novo. ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3265c447-f449-4ac5-b38b-d262a5fe99f0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27884935","allele":{"id":"https://genegraph.clinicalgenome.org/r/2caa06e3-73d2-4a74-9a2e-3d177161af96","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003412.4(ZIC1):c.1101C>A (p.Cys367Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA354898237"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/3999a8d1-23ff-43e7-9d58-112e615c260e","type":"EvidenceLine","dc:description":"Since the mechanism of disease is gain-of-function, I'm upgrading 0.9 for the functional evidence instead of 0.4. Also, there is radiographic evidence: a CT scan at 2.5 months showed bilateral coronal and right lambdoid suture fusion. An MRI brain scan at 16 months revealed a short, broad corpus callosum, underdeveloped pons, and cerebellar underdevelopment. ","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3999a8d1-23ff-43e7-9d58-112e615c260e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The mutation disrupted a significant amount of zebrafish embryos and enhanced en-2 (engrailed 2) expression.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/3999a8d1-23ff-43e7-9d58-112e615c260e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26340333","allele":{"id":"https://genegraph.clinicalgenome.org/r/fd4b6f89-0cfb-4558-a1f8-965690c1a41b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003412.4(ZIC1):c.1165C>T (p.Gln389Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16042224"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/f0f5b2ce-1367-43e1-bc23-00b9cb59a063","type":"EvidenceLine","dc:description":"Since the mechanism of disease is gain-of-function, I am upgrading 0.9 for the functional evidence instead of 0.4. ","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f0f5b2ce-1367-43e1-bc23-00b9cb59a063_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The mutation disrupted a significant amount of zebrafish embryos and enhanced en-2 (engrailed 2) expression. ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/f0f5b2ce-1367-43e1-bc23-00b9cb59a063_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26340333","allele":{"id":"https://genegraph.clinicalgenome.org/r/31dc3705-d855-4f6f-abba-23df9048cc86"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/3dacd66c-3a7d-4ad9-ba3d-0c58497cc4cc","type":"EvidenceLine","dc:description":"Upgrading 0.9 instead of 0.4 for functional evidence due to gain-of-function mechanism of disease. ","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3dacd66c-3a7d-4ad9-ba3d-0c58497cc4cc_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The mutation disrupted a significant amount of zebrafish embryos and enhanced en-2 (engrailed 2) expression (PMID: 26340333).  \n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/3dacd66c-3a7d-4ad9-ba3d-0c58497cc4cc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36118902","allele":{"id":"https://genegraph.clinicalgenome.org/r/fd4b6f89-0cfb-4558-a1f8-965690c1a41b"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/8fe09e34-fe58-4837-bb33-3cb50c6ea033","type":"EvidenceLine","dc:description":"Upgrading due to detailed radiographic evidence of both proband and affected sister with mutation. Radiographs showed severe agenesis of the corpus callosum. Linked colpocephaly and symmetric white matter signaling anomalies of the periventricular and deep white matter were also evident in the images. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8fe09e34-fe58-4837-bb33-3cb50c6ea033_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30391508","allele":{"id":"https://genegraph.clinicalgenome.org/r/e5572ab1-d311-4ec2-b4e4-dc20e448a9ae","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003412.4(ZIC1):c.1214_1215insCACCATCGTG (p.Pro406ThrfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2695202085"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/d18f0fb3-1082-4103-811b-774423a620ce","type":"EvidenceLine","dc:description":"There was maternal mosaicism. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d18f0fb3-1082-4103-811b-774423a620ce_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33288889","allele":{"id":"https://genegraph.clinicalgenome.org/r/2c32bdf2-01b2-475f-8d65-a4abd6bf80a4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003412.4(ZIC1):c.1153G>T (p.Glu385Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA354898371"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e70d90a2-6365-49ac-a21f-599ff5906d88_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8a69cb41-3d44-4047-b989-f0921541b89f_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26340333","rdfs:label":"p.Gly400Arg","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/8a69cb41-3d44-4047-b989-f0921541b89f","type":"Family","rdfs:label":"p.Gly400Arg","member":{"id":"https://genegraph.clinicalgenome.org/r/2533b4f2-28ea-403a-883a-024b323cc248","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26340333","rdfs:label":"p.Gly400Arg","allele":{"id":"https://genegraph.clinicalgenome.org/r/038849d0-e78c-42a3-81b1-00dfd567b3b1"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001256","obo:HP_0001476","obo:HP_0007360","obo:HP_0000248"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/25664c62-4c1a-44cd-968a-2f86fa4df0f6_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":5,"phenotypes":["obo:HP_0001305","obo:HP_0000248","obo:HP_0001357","obo:HP_0007360","obo:HP_0001476","obo:HP_0001256","obo:HP_0000508","obo:HP_0000486","obo:HP_0000478"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/2533b4f2-28ea-403a-883a-024b323cc248"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/9823df9b-b737-4afa-b17a-6b70eae5ed03","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9823df9b-b737-4afa-b17a-6b70eae5ed03_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35591945","allele":{"id":"https://genegraph.clinicalgenome.org/r/bf9bfdb8-2e8d-4641-b51a-bfe2c23ffca4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003412.4(ZIC1):c.1172C>A (p.Ser391Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA354898413"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/50762f5a-dc61-49ae-845e-c2027d2088f7","type":"EvidenceLine","dc:description":"Upgrading for imaging. Radiographs of the skull at 9 days indicate brachycephaly, a large anterior fontanelle, and widened sagittal suture. The coronal sutures are just partly evident in the central region. Head CT scan at 9 days old shows widening of fontanelles and the mendosal, sagittal, and lambdoid sutures. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/50762f5a-dc61-49ae-845e-c2027d2088f7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32975022","allele":{"id":"https://genegraph.clinicalgenome.org/r/cfac0e07-a721-45c4-bc83-8ded38936eb9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003412.4(ZIC1):c.1183C>G (p.Pro395Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA354898436"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/8c1fb3c8-287c-4f5e-9c88-54609a4b314e","type":"EvidenceLine","dc:description":"Since the mechanism of disease is gain of function, I'm adding 0.9 for the functional evidence instead of 0.4. ","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8c1fb3c8-287c-4f5e-9c88-54609a4b314e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mutation disrupted a significant amount of zebrafish embryos and enhanced en-2 (engrailed 2) expression. ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/8c1fb3c8-287c-4f5e-9c88-54609a4b314e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26340333","allele":{"id":"https://genegraph.clinicalgenome.org/r/b86f7dd5-5fa1-41a9-943c-426b04ac392f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003412.4(ZIC1):c.1163C>A (p.Ser388Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16042223"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":11.2},{"id":"https://genegraph.clinicalgenome.org/r/e70d90a2-6365-49ac-a21f-599ff5906d88_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e70d90a2-6365-49ac-a21f-599ff5906d88_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4cce9ae3-1507-4040-b1f8-ee0bbd9ab178","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/23264f59-ba97-4c9c-9222-e9da9c546a65","type":"FunctionalAlteration","dc:description":"The mutant embryos had significantly enhanced Wnt expression and more disrupted embyros than the wildtype. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26340333","rdfs:label":"Xenopus Oocytes, truncating mutation 36 aa shorter"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b64175ae-3495-443a-bf4a-286fbdad7d73","type":"EvidenceLine","dc:description":"Since two mutations were found to have an impact (although p.Thr414Ala appears to be associated with reduced penetrance), this is scored at 1. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2b998864-31ed-48ef-a4bb-57df5608ae41","type":"FunctionalAlteration","dc:description":"Compared with the wild-type, these mutations each resulted in a statistically significant disruption of Xenopus embryos and increase in Wnt expression. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26340333","rdfs:label":"Functional alteration: Xenopus oocytes"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/e70d90a2-6365-49ac-a21f-599ff5906d88_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7cedcd5c-9e70-457e-a4c5-849eda726c6f","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/23bad53a-fa22-4793-82ea-565ba5906612","type":"Finding","dc:description":"There is extremely high expression in the cerebellum, relative to elsewhere in the body. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26340333","rdfs:label":"GTEX Expression data","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2}],"evidenceStrength":"Definitive","sequence":8015,"specifiedBy":"GeneValidityCriteria10","strengthScore":13.2,"subject":{"id":"https://genegraph.clinicalgenome.org/r/QFGkqbihEXM","type":"GeneValidityProposition","disease":"obo:MONDO_0014705","gene":"hgnc:12872","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_e70d90a2-6365-49ac-a21f-599ff5906d88-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}